Salvus Health, a Belgian startup focused on enhancing pharmacy operations, has secured €500,000 in funding to expand its smart service platform and improve patient services.

Information on the Target

Salvus Health is an innovative Belgian startup that specializes in providing a smart service platform aimed at enhancing the productivity and efficiency of pharmacists. This platform automates routine tasks such as appointment scheduling and patient reminders, allowing pharmacists to concentrate more on their advisory roles. Co-founder Philip Van den Bergh highlights the substantial workload pharmacists face, especially when they are expected to perform additional services such as vaccinations while managing their existing responsibilities. The platform also includes an integrated customer relationship management (CRM) system designed to facilitate better communication with patients, thereby improving patient care and service delivery.

Industry Overview in Belgium

The pharmaceutical sector in Belgium is renowned for its high-quality healthcare services and well-trained professionals. The industry plays a vital role in patient care, particularly in the context of an aging population that requires more frequent medical assistance. Pharmacists are increasingly being recognized as essential players within this healthcare landscape, particularly as governments begin to reimburse services such as vaccinations and medical consultations. However, despite these advancements, many pharmacists in Belgium are still struggling with outdated systems that hinder their ability to provide comprehensive patient care.

Furthermore, the Belgian healthcare system acknowledges the strategic importance of utilizing pharmacists to alleviate pressures on other healthcare providers. This is especially crucial in the post-pandemic e

View Source

Similar Deals

Bioqube Ventures, Flanders Future Tech Fund, Qbic Spica Therapeutics

2025

Seed Stage Proprietary & Advanced Pharmaceuticals Belgium
BAN Flanders, BeAngels, NXT-2, LRM, Qbic Innocens

2025

Seed Stage Hospitals, Clinics & Primary Care Services Belgium
LUMO Labs, Heran Partners, imec.istart future fund Nuclivision

2025

Seed Stage Medical Imaging Systems Belgium
Bioqube Ventures and Flanders Future Tech Fund (FFTF) Spica Therapeutics

2025

Seed Stage Proprietary & Advanced Pharmaceuticals Belgium
Seeder Fund, LRM and private investors Monsana

2024

Seed Stage Biotechnology & Medical Research (NEC) Belgium
Novo Nordisk A/S and BioGeneration Ventures Tanai Therapeutics

2024

Seed Stage Bio Therapeutic Drugs Belgium

Angelwise

invested in

Salvus Health

in 2025

in a Seed Stage deal

Disclosed details

Transaction Size: $1M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert